Literature DB >> 10684156

Glypican-3 is a novel inhibitor of insulin-like growth factor signaling.

J Filmus1, H Song, W Shi, A Duenas Gonzalez, M Kaya, D Cano-Gauci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10684156

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN： 0025-7680            Impact factor:   0.653


× No keyword cloud information.
  3 in total

1.  Expansion of interferon-gamma-producing multifunctional CD4+ T-cells and dysfunctional CD8+ T-cells by glypican-3 peptide library in hepatocellular carcinoma patients.

Authors:  Yanhui Xu; Hong Li; Rui Lin Gao; Oluwasayo Adeyemo; Maxim Itkin; David E Kaplan
Journal:  Clin Immunol       Date:  2011-02-26       Impact factor: 3.969

2.  Intratumoral reciprocal expression of monocarboxylate transporter 4 and glypican-3 in hepatocellular carcinomas.

Authors:  Kenji Yorita; Akinobu Ohno; Takahiro Nishida; Kazuhiro Kondo; Toshihiko Ohtomo; Hiroaki Kataoka
Journal:  BMC Res Notes       Date:  2019-11-09

3.  Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma.

Authors:  Ahmed Omar Kaseb; Manal Hassan; Sahin Lacin; Reham Abdel-Wahab; Hesham M Amin; Ahmed Shalaby; Robert A Wolff; James Yao; Asif Rashid; Bharathi Vennapusa; Janine Feng; Toshihiko Ohtomo
Journal:  Oncotarget       Date:  2016-10-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.